145 related articles for article (PubMed ID: 30923085)
21. Does Pretreatment Tumor Growth Hold Prognostic Information for Patients with Glioblastoma?
Stensjøen AL; Berntsen EM; Mikkelsen VE; Torp SH; Jakola AS; Salvesen Ø; Solheim O
World Neurosurg; 2017 May; 101():686-694.e4. PubMed ID: 28300718
[TBL] [Abstract][Full Text] [Related]
22. Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging.
Yamasaki F; Sugiyama K; Ohtaki M; Takeshima Y; Abe N; Akiyama Y; Takaba J; Amatya VJ; Saito T; Kajiwara Y; Hanaya R; Kurisu K
Eur J Radiol; 2010 Mar; 73(3):532-7. PubMed ID: 19250783
[TBL] [Abstract][Full Text] [Related]
23. Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.
Wang K; Wang Y; Fan X; Wang J; Li G; Ma J; Ma J; Jiang T; Dai J
Neuro Oncol; 2016 Apr; 18(4):589-97. PubMed ID: 26409566
[TBL] [Abstract][Full Text] [Related]
24. Computer-extracted MR imaging features are associated with survival in glioblastoma patients.
Mazurowski MA; Zhang J; Peters KB; Hobbs H
J Neurooncol; 2014 Dec; 120(3):483-8. PubMed ID: 25151504
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of Histogram-Profile Analysis in Ring-Enhancing Intracranial Lesions.
Kolakshyapati M; Hashizume A; Ochi K; Ueno H; Kaichi Y; Takayasu T; Takano M; Karlowee V; Akiyama Y; Awai K; Maruyama H; Sugiyama K; Kurisu K; Yamasaki F
World Neurosurg; 2019 Nov; 131():e226-e236. PubMed ID: 31349079
[TBL] [Abstract][Full Text] [Related]
26. Prognostic Predictions for Patients with Glioblastoma after Standard Treatment: Application of Contrast Leakage Information from DSC-MRI within Nonenhancing FLAIR High-Signal-Intensity Lesions.
Kim SH; Cho KH; Choi SH; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST
AJNR Am J Neuroradiol; 2019 Dec; 40(12):2052-2058. PubMed ID: 31727756
[TBL] [Abstract][Full Text] [Related]
27. Correlation of post-contrast T1-weighted MRI surface regularity, tumor bulk, and necrotic volume with Ki67 and p53 in glioblastomas.
Hasse A; Dapash M; Jeong Y; Ansari SA; Carroll TJ; Lesniak M; Ginat DT
Neuroradiology; 2019 Aug; 61(8):861-867. PubMed ID: 31020343
[TBL] [Abstract][Full Text] [Related]
28. High-resolution blood-pool-contrast-enhanced MR angiography in glioblastoma: tumor-associated neovascularization as a biomarker for patient survival. A preliminary study.
Puig J; Blasco G; Daunis-I-Estadella J; Alberich-Bayarri A; Essig M; Jain R; Remollo S; Hernández D; Puigdemont M; Sánchez-González J; Mateu G; Wintermark M; Pedraza S
Neuroradiology; 2016 Jan; 58(1):17-26. PubMed ID: 26438560
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.
Yamamoto J; Kakeda S; Shimajiri S; Nakano Y; Saito T; Ide S; Moriya J; Korogi Y; Nishizawa S
World Neurosurg; 2018 Dec; 120():e719-e729. PubMed ID: 30165229
[TBL] [Abstract][Full Text] [Related]
30. Multifocal and multicentric glioblastoma: Improved characterisation with FLAIR imaging and prognostic implications.
Lasocki A; Gaillard F; Tacey M; Drummond K; Stuckey S
J Clin Neurosci; 2016 Sep; 31():92-8. PubMed ID: 27343042
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of contrast enhancement and FLAIR for survival in newly diagnosed glioblastoma treated with and without bevacizumab: results from ACRIN 6686.
Boxerman JL; Zhang Z; Safriel Y; Rogg JM; Wolf RL; Mohan S; Marques H; Sorensen AG; Gilbert MR; Barboriak DP
Neuro Oncol; 2018 Sep; 20(10):1400-1410. PubMed ID: 29590461
[TBL] [Abstract][Full Text] [Related]
32. Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival.
Lasocki A; Gaillard F; Tacey M; Drummond K; Stuckey S
J Clin Neurosci; 2018 Jan; 47():168-173. PubMed ID: 28988652
[TBL] [Abstract][Full Text] [Related]
33. Multicenter imaging outcomes study of The Cancer Genome Atlas glioblastoma patient cohort: imaging predictors of overall and progression-free survival.
Wangaryattawanich P; Hatami M; Wang J; Thomas G; Flanders A; Kirby J; Wintermark M; Huang ES; Bakhtiari AS; Luedi MM; Hashmi SS; Rubin DL; Chen JY; Hwang SN; Freymann J; Holder CA; Zinn PO; Colen RR
Neuro Oncol; 2015 Nov; 17(11):1525-37. PubMed ID: 26203066
[TBL] [Abstract][Full Text] [Related]
34. Age groups related glioblastoma study based on radiomics approach.
Li Z; Wang Y; Yu J; Guo Y; Zhang Q
Comput Assist Surg (Abingdon); 2017 Dec; 22(sup1):18-25. PubMed ID: 28914549
[TBL] [Abstract][Full Text] [Related]
35. Analysis of peritumoral hyperintensity on pre-operative T2-weighted MR images in glioblastoma: Additive prognostic value of Minkowski functionals.
Choi Y; Ahn KJ; Nam Y; Jang J; Shin NY; Choi HS; Jung SL; Kim BS
PLoS One; 2019; 14(5):e0217785. PubMed ID: 31150499
[TBL] [Abstract][Full Text] [Related]
36. Preoperative Two-Dimensional Size of Glioblastoma is Associated with Patient Survival.
Leu S; Boulay JL; Thommen S; Bucher HC; Stippich C; Mariani L; Bink A
World Neurosurg; 2018 Jul; 115():e448-e463. PubMed ID: 29678715
[TBL] [Abstract][Full Text] [Related]
37. MR Imaging Characteristics Associate with Tumor-Associated Macrophages in Glioblastoma and Provide an Improved Signature for Survival Prognostication.
Zhou J; Reddy MV; Wilson BKJ; Blair DA; Taha A; Frampton CM; Eiholzer RA; Gan PYC; Ziad F; Thotathil Z; Kirs S; Hung NA; Royds JA; Slatter TL
AJNR Am J Neuroradiol; 2018 Feb; 39(2):252-259. PubMed ID: 29191871
[TBL] [Abstract][Full Text] [Related]
38. Quantitative imaging study of extent of surgical resection and prognosis of malignant astrocytomas.
Kowalczuk A; Macdonald RL; Amidei C; Dohrmann G; Erickson RK; Hekmatpanah J; Krauss S; Krishnasamy S; Masters G; Mullan SF; Mundt AJ; Sweeney P; Vokes EE; Weir BK; Wollman RL
Neurosurgery; 1997 Nov; 41(5):1028-36; discussion 1036-8. PubMed ID: 9361056
[TBL] [Abstract][Full Text] [Related]
39. Nonenhancing peritumoral hyperintense lesion on diffusion-weighted imaging in glioblastoma: a novel diagnostic and specific prognostic indicator.
Kolakshyapati M; Adhikari RB; Karlowee V; Takayasu T; Nosaka R; Amatya VJ; Takeshima Y; Akiyama Y; Sugiyama K; Kurisu K; Yamasaki F
J Neurosurg; 2018 Mar; 128(3):667-678. PubMed ID: 28362236
[TBL] [Abstract][Full Text] [Related]
40. Prognostic Value of Dynamic Susceptibility Contrast-Enhanced and Diffusion-Weighted MR Imaging in Patients with Glioblastomas.
Çoban G; Mohan S; Kural F; Wang S; O'Rourke DM; Poptani H
AJNR Am J Neuroradiol; 2015 Jul; 36(7):1247-52. PubMed ID: 25836728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]